Vertigo, a common clinical symptom, presents as a sensation of spinning or feeling off-balance. It is often associated with a range of vestibular disorders. This article aims to provide a comprehensive clinical approach to diagnosing and managing vertigo.
Vertigo is not a disease but a symptom that can result from various conditions, most commonly peripheral vestibular disorders. It can also be a sign of central nervous system disorders. Differentiating between peripheral and central vertigo is crucial for accurate diagnosis and treatment.
An accurate history is the primary tool for diagnosing vertigo. The onset, duration, frequency, and associated symptoms can provide valuable clues. Physical examination, including a neurological examination and specific tests like the Dix-Hallpike maneuver, can help identify benign paroxysmal positional vertigo (BPPV).
Imaging studies like MRI or CT scans may be required to rule out central causes. Vestibular function tests, such as electronystagmography (ENG) or videonystagmography (VNG), can provide objective evidence of peripheral vestibular dysfunction.
Management of vertigo depends on the underlying cause. BPPV, the most common cause of vertigo, can often be treated with canalith repositioning maneuvers. Medications can alleviate symptoms in some cases, while vestibular rehabilitation therapy (VRT) can help patients cope with chronic vertigo.
Vertigo is a challenging symptom that requires a thorough and systematic approach to diagnosis and management. By understanding its various causes and utilizing appropriate diagnostic tools, healthcare professionals can effectively manage patients with vertigo and significantly improve their quality of life.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation